ANGEL LUIS GUERRERO PERAL-rekin lankidetzan egindako argitalpenak (19)

2024

  1. Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients

    Life, Vol. 14, Núm. 7

  2. Evaluation of the burden of migraine on the partner's lifestyle

    Neurologia, Vol. 39, Núm. 9, pp. 810-819

2023

  1. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles

    Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239

  2. Increased MRI-based Brain Age in chronic migraine patients

    Journal of Headache and Pain, Vol. 24, Núm. 1

  3. Structural brain changes in patients with persistent headache after COVID-19 resolution

    Journal of Neurology, Vol. 270, Núm. 1, pp. 13-31

  4. Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies

    Frontiers in Neuroscience, Vol. 17

2021

  1. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092

  2. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091

  3. Multimodal fusion analysis of structural connectivity and gray matter morphology in migraine

    Human Brain Mapping, Vol. 42, Núm. 4, pp. 908-921

  4. Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study

    Scientific Reports, Vol. 11, Núm. 1

  5. Temporal distribution of emergency room visits in patients with migraine and other headaches

    Expert Review of Neurotherapeutics, Vol. 21, Núm. 5, pp. 599-605

2020

  1. Alternative microstructural measures to complement diffusion tensor imaging in migraine studies with standard MRI acquisition

    Brain Sciences, Vol. 10, Núm. 10, pp. 1-36

  2. Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis

    Frontiers in Neurology, Vol. 11

  3. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study

    Journal of Headache and Pain, Vol. 21, Núm. 1

  4. Gray matter structural alterations in chronic and episodic migraine: A morphometric magnetic resonance imaging study

    Pain Medicine (United States), Vol. 21, Núm. 11, pp. 2997-3011

  5. Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients

    Cephalalgia, Vol. 40, Núm. 13, pp. 1432-1442

  6. Response prediction for chronic migraine preventive treatment by gray matter morphometry in magnetic resonance imaging: A pilot study

    Revista de Neurologia, Vol. 71, Núm. 11, pp. 399-406

  7. Structural connectivity alterations in chronic and episodic migraine: A diffusion magnetic resonance imaging connectomics study

    Cephalalgia, Vol. 40, Núm. 4, pp. 367-383

  8. White matter changes in chronic and episodic migraine: A diffusion tensor imaging study

    Journal of Headache and Pain, Vol. 21, Núm. 1